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Chapter 5
Incongruities and Dilemmas in Data 
Donation: Juggling Our 1s and 0s
Kerina H. Jones
Abstract The creation of vast, complex datasets made possible by technological 
advances over recent decades, has resulted in data becoming big business across 
many sectors and disciplines world-wide. Everyday life is increasingly networked 
via a growing array of digital devices to which individuals provide data, passively 
and actively. The pace of development has led to questions about the role of such 
‘data donors’ and how individuals can be safeguarded when they might not be fully 
cognisant of the extent or destinations of data provided. We show that the many 
ways in which individuals provide data about themselves can result in incongruities 
and dilemmas in apparent decision making. We argue that it is not ethical for the 
vast swathes of data provided by individuals not to be used for public good. We explore 
whether we can make truly informed choices with the panoply of issues that may 
influence our decisions. We conclude without a straightforward yes or no, but pro-
pose that if we provide the best available information and engage with information 
presented, we stand a more reasonable chance. Do that, there is a need for demon-
strable trustworthiness and clarity, greater awareness so that trust can be placed 
wisely, and for us to hone our juggling skills.
Keywords Data donation · Incongruities · Dilemmas · Big data · Tissue/organ 
donation
5.1  Introduction
The etymology of the word ‘donation’ is from the latin ‘donum’ meaning ‘gift’, 
with the French ‘donner’, to give, being a familiar derivative. It has been proposed 
that it can be easier to donate blood and even organs than to donate our data. This 
appears incongruous, and raises questions about the contexts and rationales for 
these positions. Using the donation of general personal data and health data in 
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example scenarios, this discursive chapter explores areas such as: alternative con-
sent models; the unknown element in data content; trust and trustworthiness in data 
custodians; and meaningful public engagement, to consider the bioethical balance 
between individual autonomy, personal exploitation and social responsibility. 
Ultimately, the question is whether we, as individuals and society, can make truly 
informed choices with the panoply of issues that may influence our decisions, creat-
ing dilemmas as we juggle our 1s and 0s.
5.2  Hast Thou Which Art but Data, a Touch, a Feeling?1
Digital data at the most fundamental level is represented as a combination of 1s and 
0s. Over recent decades, major technological advances have enabled the creation of 
vast, complex datasets commonly referred to as ‘big data’. Big data is big business: 
it has been estimated that its worth to the UK will exceed £320 billion by 2020, and 
that in the US, the m-health app market alone will reach almost $60 billion in the 
same timescale (Greenbaum 2018; City a.m. 2017). There is a global profusion of 
enterprises seeking to make the best use of person-based data to inform policy, 
health and other public services, business, marketing and an array of other commer-
cial and non-commercial developments for public good and/or profit. There has 
never been such a high demand for our personal data to be donated, such that it is 
often said that individuals are the product, not just the client (Wu 2017). But before 
we begin considering data donation, it’s worth highlighting that data ownership is a 
tricky concept in law. It’s something we often refer to informally e.g. my data, your 
data, but laws of ownership mainly relate to people owning tangible items, such as 
objects or property, and data does not fit neatly into these categories. The question 
arises as to how someone can be said to own data, since in order to be meaningful, 
ownership should confer a concept of possession. Furthermore, tangible items are 
generally exhaustible whereas data are not, but can be used repeatedly by multiple 
parties for multiple purposes ad infinitum. With this in mind, it is indeed difficult to 
see how someone can be said to own their data since once the data are known to 
others, the person no longer has real control over their fate.
Rather than ownership, data protection legislation and regulations relate to safe-
guarding the privacy of data subjects and the confidentiality of the information in 
question. Within the EU, we have seen the recent introduction of the General Data 
Protection Regulation (GDPR, EU GDPR portal 2018), with concomitant national 
legislation, marking an overhaul in the way personal data are governed. The GDPR 
enhances the rights of individuals as data subjects, and it places a greater onus on 
data controllers and processors to justify proactively their lawful basis for using 
personal data, including providing suitable privacy notices for data subjects. But it 
doesn’t ultimately change the fundamental focus on data protection rather than data 
ownership.
1 Hast thou, which art but air, a touch, a feeling. (Shakespeare, The Tempest).
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Article 4 (1) of the GDPR (Intersoft consulting 2017) defines personal data as: 
‘any information relating to an identified or identifiable natural person’, and ‘an 
identifiable natural person’ as ‘one who can be identified, directly or indirectly, in 
particular by reference to an identifier such as a name, an identification number, 
location data, an online identifier or to one or more factors specific to the physical, 
physiological, genetic, mental, economic, cultural or social identity of that natural 
person’. Article 6 (1) sets out the six lawful bases for general data processing, and 
Article 9 sets the provisions for processing special category data, which is defined 
as: ‘personal data revealing racial or ethnic origin, political opinions, religious or 
philosophical beliefs, or trade union membership, and the processing of genetic 
data, biometric data for the purpose of uniquely identifying a natural person, data 
concerning health or data concerning a natural person’s sex life or sexual orienta-
tion ’ (Intersoft consulting 2017). Even so, it can be argued that we haven’t yet 
uncovered all the types of data that could be seen as personal, and which could yet 
necessitate a further update in legislation. We are seeing a rapid increase in con-
nectedness via urban monitoring, the internet of things and smart objects, some 
within our own homes or even as our clothing (Engineering & Technology 2017). 
Interestingly, the Article 29 Working Party on Data Protection already broadens the 
scope of health data, accepting that lifestyle data may constitute health data if they 
are inherently related to a person’s health status (Article 29 Data Protection Working 
Party 2013). We engage in in-depth (sometimes rather personal) conversations on 
social media, accept store loyalty cards which track our purchases, and use a variety 
of lifestyle apps on our devices. The genomic revolution is opening up untold oppor-
tunities for research and medicine, that were not available just a few years ago. 
There is a myriad of occasions where we donate our data, either actively or pas-
sively, as we go about our daily business or take part in dedicated activities. 
Altogether we are creating a rich data footprint, sometimes without knowing which 
types of data have been collected, by whom, or even having no awareness of them 
at all.
5.3  What We Might Be Donating
For the purpose of this chapter, we will stick with the concept of donation as gifting 
something to another party or parties, even though it is not as straightforward in the 
donation of data as it is for more tangible objects. Our data subject, let’s call him 
Schrödinger’s Pat2, might passively or actively donate personal data from many 
sources to various parties, over the course of his life or after his death. This may 
include data from his: health and administrative records, DNA, social media posts, 
mobile phone call detail records, apps, and store loyalty cards. He might also donate 
blood, stem cells, tissue samples and paired organs during his life, then vital organs 
2 Schrödinger’s cat: a quantum physics thought experiment where a cat may be simultaneously 
alive and dead.
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or his whole body after his death. Importantly to remember is that whatever is 
donated, data are being generated.
Pat might donate general and special category data to different parties for differ-
ent purposes, with or without his full awareness. It can be easy, possibly too easy, to 
donate data in some instances. For example, we readily sign up for store loyalty 
cards on the promise of discounts or rewards, but it is important to remember that 
the data collected as we shop is of more value to the store than any benefits to the 
customer. Similarly with social media platforms; we gain the benefits of social con-
tact, but our data may be used to target us for marketing and sometimes for other 
reasons. The recent Facebook debacle over psychological profiling by Cambridge 
Analytica is a case in point, where it has been alleged that personal data from a 
personality quiz on Facebook was used to try and manipulate voting intentions. 
People engaging in the quiz were unwittingly providing detailed information about 
themselves to be used for illicit purposes (Solon and Graham-Harrison 2018).
Pat might also choose to use health or fitness apps which collect special category 
data, such as diagnoses, medications and medical symptoms. Or he may choose to 
engage with a Direct to Consumer (DTC) DNA sequencing company to find out 
about his genetic susceptibility to certain conditions. DTCs provide information to 
customers for a fee, but generally use the data for business development, research 
and to sell to third parties in anonymised or aggregated form. Questions have been 
raised about the rectitude of DTC services, since individuals might be ill-equipped 
to deal with the results, and the actual predictive value of the information provided 
might not live up to company marketing promises (Cussins 2018). Some countries 
have banned DTCs and others are considering their legislation in this regard 
(Kalokairinou et al. 2017).
As well as donating data (in the form of data) Pat might donate blood, tissue or 
organs during the course of his life, or after his death. This, of course, also generates 
data. Within Wales, and soon to be implemented in England, there is an opt-out 
consent mechanism whereby a person donates their organs after death, unless they 
had previously opted out. It is an interesting incongruity that we have an opt out 
system for organ donation after death, but we do not have a similar arrangement in 
place for data donation after death. Yet, organs can be used to generate rich data, 
including full genome sequences of living relatives of the deceased, and thus may 
uncover highly-sensitive familial information compared to health record data that, 
paradoxically, cannot be shared in this way. However, it could be argued that it is the 
opt out consent system for posthumous organ donation that is ethically at fault, 
since a forced or presumed gift loses the spirit of being a gift (McCartney 2017). 
The question arises as to whether we can be sure the public genuinely feel they were 
informed about the process, or if a significant proportion just haven’t engaged, and 
simple inertia has prevented them from going on-line to opt out. We will explore this 
concept in more detail.
K. H. Jones
79
5.4  Are We at Least with Socrates?
Whether or not Socrates actually said he was the wisest man because he was aware 
he knew nothing, it is an apt sentiment in gauging our own perspectives, and one we 
can apply in relation to data donation. For the many ways in which Pat might donate 
data in one form or another, the level to which he is informed and the nature of 
consent may vary widely. Medical research is generally well-regulated but, across 
other domains, Pat may give his permission to donate data via everything from 
properly informed consent to ‘agreeing’ to lengthy terms & conditions. This is a 
common problem and one for which there has been a number of social experiments. 
In a survey completed by 550 DTC customers, most respondents considered them-
selves aware of privacy issues, and the risk of troubling repercussions of data dona-
tion to be negligible. But over 50% men and almost 30% women also said they had 
not read the terms & conditions (Haeusermann et al. 2017). Among a group of over 
500 students signing up to a fictitious social media channel, none of them read the 
terms & conditions well enough to notice that they had agreed to hand over their 
first-born child (Technica UK 2016). These studies warrant an exclamation mark(!) 
and leave us in doubt about the adequacy of consent processes in some spheres. 
They highlight the dilemma of where the responsibility lies in engaging properly 
with the public, as to whether the onus should be more on the individual or the data 
collector. In answer to our own Socratic question, it appears that no, we often don’t 
know that we don’t know.
5.5  Legal Position – Data vs Tissue
The EU GDPR, and related new national legislation, might be the hero to save us 
from some of these difficulties. Under the GDPR, the requirements for valid 
informed consent have been tightened, such that Recital 32 states that ‘consent 
should be given by a clear affirmative act establishing a freely given, specific, 
informed and unambiguous indication of the data subject’s agreement to the pro-
cessing of personal data relating to him or her’ (Intersoft consulting 2017). This 
places new limits on the use of opt-out consent mechanisms and on the use of 
lengthy, tiny wordy, scrolly downy, nobody readsy, terms & conditions. This move, 
together with the requirement for greater clarity on data processing in privacy 
notices, the right of individuals to request a copy of data pertaining to them, and the 
right of data erasure, serves to empower individuals on the use of their personal 
data. As soon as the GDPR came into force, complaints were brought against 
Facebook, Google and others, alleging that companies are forcing users to accept 
targeted advertising, or to delete their accounts (Foxx 2018). If these complaints are 
upheld, and as more users become aware of their rights, this could result in serious 
financial and reputational damage for these companies. Hopefully, it will bring 
about a change in practice to respect data donors and comply properly with the 
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regulations. Other social media giants, notably Twitter, have introduced clear, gran-
ular controls that allow users more choice, including opting out of targeted advertis-
ing which relies on user profiling (Foxx 2018).
We have already mentioned posthumous organ donation, but there is also tissue 
and organ donation from living individuals to consider, with the corresponding 
implications for the individuals and their kin. The UK, in common with many coun-
tries, has specific legislation governing the donation of human tissue from living 
individuals (UK Human Tissue Act 2004). Organisations processing human tissue 
must be licensed, abide by strict protocols and are subject to inspections by regula-
tory authorities. However, with the advancing genomic revolution, tissue donated 
by one consented individual can generate increasingly rich information about the 
donor and their kin, as the secrets of DNA are being uncovered. Yet, it would not be 
practicable or ethical to seek consent from all the possibly relevant individuals. For 
bone fide organisations we rely on good governance regimes for data management 
and access; but with the explosion of interest in genomic data, and huge multina-
tional companies such as Apple, Google and Amazon entering the health market, it 
is not known what the future holds or whether the ensuing power-play will yet 
trump bioethical factors one way or another (Scott 2018).
5.6  No Man Is an Island Entire of Itself3
When Pat chooses whether to donate any kind of personal data about himself, he 
needs to remember that his decision will have implications for others. On the basis 
of Western philosophy, we lean on the side of individual autonomy in our bioethical 
principles. The four main principles we commonly rely on being: (i) the rights of 
individuals to make decisions and to be provided with truthful, complete informa-
tion to be able to make a properly informed choice, free from coercion (autonomy); 
(ii) not intentionally harming individuals through acts of commission or omission, 
and providing standards of care meeting the law and commonly held moral convic-
tions (non-maleficence); (iii) a duty to benefit individuals, and actively preventing 
harm (beneficence); and (iv) equality and fairness in the provision of care and dis-
tribution of resources by seeking to overcome disadvantages (justice) (Beauchamp 
and Childress 2013). But, if we are to give due consideration to data donation, 
individuals also have to face the concept of social responsibility, with the added 
dilemma of whether in the act of donating we are potentially benefitting or harming 
others associated with us. This can be the case in many contexts, and it not limited 
to the obvious genomic data example. It has been observed that some apps used on 
social media platforms seek access to the user’s contact list and photographs, and it 
is worth carefully reviewing privacy settings to be sure we are aware of the data 
donation ‘choices’ we are making (Denholm 2016).
3 No man is an island (John Donne).
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Although we have referred to bioethical principles, it is interesting to consider 
the extent to which our data donation decisions are based on bioethics or on other 
considerations altogether. When we donate personal data to a research project hav-
ing a defined protocol, clear aims and anticipated outcomes, with potential risks and 
benefits for participants, we could reasonably say we choose our position based on 
our moral perspectives. We might hope for benefits for ourselves, or we might be 
acting altruistically in undergoing an intrusive process purely for the future benefit 
of others, based on a sense of social responsibility. But when we donate data in other 
contexts, such as social media, it is doubtful that we base our decisions on ethics. 
Similarly with choosing to use an app, a DTC company, or a mobile phone contract. 
A key difference seems to be in the purpose of the transaction. Participating in a 
research project carries the concept of ‘giving something back’ and thus contribut-
ing to the good of society. Signing up to use a service or product, however, is rather 
different, as it is directly associated with obtaining something based on need or 
desire. As we’ve observed, we are often presented with a potentially coercive situa-
tion where we can only obtain the item if we enter into the agreement. Ironically, we 
are often taken stepwise through a process to donate data to research for public 
good, with much less attention paid as we rush to complete the transaction to gain 
the prize in the latter scenarios. Furthermore, the extent to which the companies 
with whom we engage are acting on the four ethical principles might be highly vari-
able when profit is their primary purpose. In some cases, this might be more akin to 
personal exploitation by platforms of largely unaccountable power.
5.7  Data, Data Everywhere, nor any Chance to Think4
So if it’s only partly about bioethics, it will be valuable to consider what else shapes 
Pat’s choices and the norms of society concerning data donation. We have noted that 
data might be provided passively or actively and in multiple contexts as we go about 
our daily lives. In general, we are all subject to vast amounts of potentially influen-
tial information from many sources. Unlike in the past, our challenge is not in find-
ing information, but in knowing how to be judicious in selecting what is reliable 
enough to guide our decisions. Depending how we view the commonly-referred to 
‘information society’, we might see ourselves as the most privileged generation yet, 
or the one most subject to the attention merchants (Wu 2017). Estimates vary, but 
reviews indicate that about 2.5 million academic articles are published every year, 
challenging professionals to keep abreast of cutting edge knowledge to inform their 
practice (Ware and Mabe 2015). As members of the public with our respective areas 
of expertise and ignorance, we are bombarded with information on any number of 
topics from multiple angles and media outlets. It is difficult to ignore information 
once it is known to us: it is assessed for its value or resides in our subconscious 
4 Water, water everywhere, nor any drop to drink (The Rime of the Ancient Mariner, Samuel Taylor 
Coleridge).
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waiting to become relevant. Altogether, we are subject to a vast, shifting body of 
knowledge that floats around shaping our social realities.
We might sometimes be relatively disengaged, and perhaps we need to be, from 
much of the information that comes our way. If we were to ask people travelling on 
a train, or in another common social setting, whether they have donated any data 
today, we are likely to receive puzzled looks or responses in the negative. Yet, unless 
we are disconnected from the digital realm, it is highly unlikely that we have not 
donated data in some form to someone over the course of a day. But, at times, we 
may find ourselves in a position where we need to make important decisions about 
data donation. It is on these days where we hit the personal threshold, that our 
worldview and bioethical principles come to the fore, and we find ourselves needing 
to draw upon the information available to us to navigate a moral maze. This might 
relate to decisions about our own (or a loved one’s) health, finances, education or 
any of an array of issues that may impact on our personal lives, taking us beyond our 
public personas and into the domain we consider private. At times like this, we are 
likely to become more concerned that we can trust the recipients of our data and 
their motives, as we have to move out of our, sometimes, blasé bubbles. But by this 
time, we are already likely to have a substantial data footprint, which may not have 
been donated so thoughtfully. Perhaps it is time to re-evaluate.
5.8  Up in the Air
All things considered, we propose that there are indeed incongruities in data dona-
tion, and that we find ourselves juggling our 1s and 0s between different parties and 
purposes. Taking Pat as our data subject, he might donate different types of data via 
the same basic decision-making process, or the same data via very different pro-
cesses. For example, if he uses a variety of apps, he is able to donate general per-
sonal data such as his location via a fitness monitoring app, or his medical data via 
a health-monitoring app reminding him when to take his medication or recording 
self-reported symptoms to monitor a chronic condition. Alternatively, and more 
starkly, he might donate health (including genomic) data to a company by remote 
agreement to terms & conditions via a web-based agreement form. Or he might 
donate the very same data to a medical researcher as part of a clinical trial, via one- 
to- one consultation carried out on a face-to-face basis. As mentioned above, the 
legitimacy of DTC companies is in question in some domains (Kalokairinou et al. 
2017), but perhaps we should also be more cognisant about health-monitoring apps 
that are not controlled solely by our care provider, but are run by third parties pri-
marily for gain arising from the data harvested. It is possible that when our deci-
sions are made remotely, in the ‘privacy’ of our own homes, our attention is 
cocooned by the sense of security created by our familiar environment. But of 
course, this is irrelevant for digitally-connected transactions even if we may feel 
‘safe’ when signing up on our own device. In some scenarios, Pat could be in the 
position of not knowing the recipients of his data, exactly what data items have been 
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collected, or what will be done with them by whom. The original recipient may 
further process the data and pass it on, or sell it, to other parties albeit in anonymised 
format.
5.9  Through a Glass Darkly5
In these respects, it can be too easy to donate personal data, as even if data have been 
through a process of anonymisation, it might not be impossible to derive some iden-
tifiable information from within them by attribution. This is commonly referred to 
as ‘jigsaw’ or ‘mosaic’ attack and in some cases can lead re-identification (UK 
Anonymisation Network 2018). Many studies have shown that the removal of com-
monly recognised identifiers (such as name and address) is insufficient to render a 
dataset truly anonymous. This is because of residual risks due to the presence of 
unique records. As a possibly surprising example, 87% of people in the US have 
been shown to have a unique combination of birth date, sex and zip code. Such 
information provides a fast-track to uncovering individual identity and has led some 
authors to lament the broken promises of anonymisation (Ohm 2010). Uncovering 
individual identity is a sufficient problem in itself, but it doesn’t stop there. By using 
information from public sources and anonymised health data, it has been shown that 
the confidential health records of specific individuals can be uncovered. Famously, 
this occurred to a Governor of Massachusetts, where a researcher deduced and sent 
his health records to his office with ‘theatrical flourish’ (Ohm 2010)! This problem 
further extends to genomic data, with its implications for kin as well as for the data 
donor. Researchers used an open-access genetic database detailing short tandem 
repeats on the Y-chromosome, and used genetic similarity to infer familiality in the 
paternal line. By combining these similarities with information on a publically- 
accessible genealogy database containing surnames, they were able to reveal cases 
where recorded paternity and genetics did not correspond. This could obviously 
have serious implications for the personal lives and familial relationships of the data 
donors (Gymrek et al. 2013). Clearly, there needs to be something more than pur-
ported anonymisation if Pat’s privacy is to be secured.
All is certainly not lost as there are many bone fide enterprises across the world 
where privacy-by-design is an integral concept with a strong emphasis on good data 
governance6. Privacy-by-design is an important whole system concept where a suite 
of controls is built in at all stages in working with person-based data (Intersoft con-
sulting 2017). The environment surrounding the data is designed to be conducive to 
safe data storage and use, providing stronger data governance regimes than relying 
5 1 Corinthians 13:12 (The Holy Bible).
6 International examples  – Secure Anonymised Information Linkage Databank https://saildata-
bank.com/; Institute for Clinical and Evaluative Sciences https://www.ices.on.ca/; Population Data 
BC https://www.popdata.bc.ca/; Population Health Research Network http://www.phrn.org.au/; 
and Scottish Informatics and Linkage Collaboration http://www.datalinkagescotland.co.uk/
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on data curtailment alone. It can be a challenge to strike the optimum balance 
between data privacy and utility, as controls applied to datasets to limit the risk of 
disclosure may compromise research utility. Some examples could be aggregating 
age into 10-year bands, or suppressing outlying variables, depending on the research 
question of interest. It can be easy to be drawn into what has been termed ‘privacy 
perfectionism’, where superfluous controls are applied to datasets diminishing data 
utility but without providing additional safeguards (Allen et al. 2013). This is where 
privacy-by-design comes in as it combines physical, technical and procedural con-
trols to provide more robust and flexible data protection (Jones et al. 2014; Pencarrick 
Hertzman et al. 2013).
As well as addressing the safe use of health data in general, there is considerable 
debate in the literature over whether genetic data need to be treated as a special case 
for data protection. This has been termed ‘genetic exceptionalism’ (Chin and 
Campbell 2013). As a concept, it flies in the face of some current initiatives, which 
aim to make genetic data open and publically-accessible. This is the established pat-
tern with platforms for genome referencing and genome-wide association studies 
(GWAS) (GeneCards 2018), but more recently, there are initiatives where genetic 
data together with general health data (sometimes plus demographics) are being 
shared openly. An example of this is the Personal Genome Project (PGP) (Personal 
Genome Project 2018) where individuals engaging with the project can choose to 
make their linked health and genetic data publically accessible via a website. The 
PGP is clear in the information it provides to participants, including the possible 
risks to their privacy, such that individuals engage with their eyes open (providing 
they read the information properly!). Sharing data in this way can be seen as an 
impressive altruistic gesture, but it does also raise risks for the individual and their 
kin, as we have alluded to earlier. Relatives of a data donor may unwittingly be 
exposed to others knowing their estimated likelihood of developing a genetic condi-
tion, or of the information falling into the hands of parties who might use it to deny 
them employment or insurance. It is noteworthy that the GDPR does not especially 
single out genetic data, but classifies them along with general health data under 
Article 9 (Intersoft consulting 2017). Research has shown that among the general 
public there is almost an even split among those who think genetic data is different 
to other health data and those that either do not, or who are unsure (52% yes; 48% 
no/unsure) (Global Alliance for Genomics and Health 2017). The bioethical debate 
continues and is likely to do so for some time with new revelations being made 
about the genome. Without wishing to raise concerns unnecessarily, as individuals 
considering our options in donating data, we need to move away from the naïve 
concept that data are anonymised just because we are told this is the case. Again we 
come back to the judicious use of information from the plethora available to us, and 
the challenges this presents.
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5.10  Life Through a Lens (Or Several)
By the time the information on which we base our data donation choices reaches us, 
it is likely to have passed through a number of filters affecting its interpretation and 
presentation to us, as well as to decision makers who may be acting on our behalf. 
Concepts can be magnified, diminished or fragmented as information passes via a 
series of intermediaries, with their interpretations acting as lenses, variously refract-
ing the information and influencing the next steps. A decision maker has to be judi-
cious in use of the information available in making choices affecting the use of their, 
or another’s data, but information provenance might not be fully known.
This is a universal problem, not limited to the information sources already con-
sidered. Importantly, this also highlights challenges in the interpretation and imple-
mentation of privacy legislation and information governance frameworks, which 
may influence our decisions, and those who provide us with guidance. In a review 
of harms arising from the use of health and biomedical data, it was shown that the 
most prevalent cause of data misuse was the maladministration of data governance, 
rather than wilful data abuse (Laurie et al. 2015; Stevens et al. 2017). This included 
failures to follow correct procedures, despite guidance and the existence of standard 
procedures and protocols, and failures to take action to avoid data misuse taking 
place. The report included recommendations for improved staff training amongst 
other measures to strengthen information governance practice (Laurie et al. 2015; 
Stevens et al. 2017). However, as well as protecting proper individual privacy and 
safeguarding professionals, it can sometimes be the case that rules are over- stringent 
or their true essence is lost in translation.
The review also covered harm due to the non-use of health data. This is seen as a 
distinct issue and not merely the reverse of gaining the benefits of data used prop-
erly. This aspect of the work showed that there are instances where poor information 
governance can result in serious repercussions for individuals and society. Some 
pertinent causes of this problem were: lengthy and duplicative approval processes, 
conflicting advice, and excessive disclosure controls applied to de-identified data, 
limiting its utility. The apparent reasons were often quite straightforward but prob-
lematic nonetheless. They included: unclear lines of responsibility, fear of making 
the wrong decisions, and alterations to organisational data governance frameworks 
in the absence of legislative or regulatory changes. As a result, there can be a skew 
or deficit in the information available to data donors, like Pat, and the professionals 
who provide his care (Jones et al. 2017). We will return to the issue of data non-use 
later in this chapter. As a general rule whether we’re acting as individuals or profes-
sionals, we should always seek the most definitive information, as close to the pri-
mary source as possible, when we make decisions on donating data. But, of course, 
we may not know the derivation of the information that reaches us, and this may 
leave us with a dilemma we can’t really quantify, whilst needing to proceed one way 
or the other.
5 Incongruities and Dilemmas in Data Donation: Juggling Our 1s and 0s
86
5.11  Minding Our Ps and Qs
So, with all this in mind, let’s look at what we can do to raise realistic awareness. 
One major action is to stop asking questions that cannot be answered. In engaging 
with the public, there is little point in simply asking whether people think their per-
sonal data should be used or not. Sometimes data have to be used for various essen-
tial purposes, and at other times data are being used with negligible regard for social 
acceptability. Public engagement researchers have mostly moved on to asking more 
focused and answerable questions, such as how data should be used and by whom. 
In seeking to make public engagement meaningful, there is a need to be upfront 
about what we know and what we do not know. Keeping with tradition, we can use 
some alliteration in elaborating this point. These are at least some of the unknown 
Ps we need to grapple with: the package (the data content); the parties (the data 
users); the purpose (the data uses); and the places (the data environment).
Unless Pat obtains a copy, he would not be alone in not knowing the full details 
of data held about him by a given data controller. As an aside, with the introduction 
of the GDPR, he is now in a position where he may request this is if he wishes to do 
so (Intersoft consulting 2017). Two key areas where the unknown package is likely 
to be most pronounced, but for different reasons, are on major social media, search 
and retail platforms and in genomic data. It is well-known that companies such as 
Facebook, Google and Amazon use advanced data-scraping algorithms to source as 
much online information as possible about their users. This puts Pat in a position, 
whether he’s aware of it or not, that he really doesn’t know the scope or extent of 
data held about him and his online activities. On the contrary, with genomic data, it 
is the full meaning of the dataset itself that is unknown. Even with a copy of the 
data, Pat would not know what it all means, since that knowledge is just not avail-
able. In these scenarios, when we donate data we do so without fully knowing what 
they contain.
When the public are asked, they generally express differing levels of willingness 
to donate data to different parties. Unsurprisingly, the trend is usually in favour of 
non-commercial organisations and less so for the commercial sector. This is true for 
general health data, administrative data arising from other public services and, 
unsurprisingly, for genomic data (Global Alliance for Genomics and Health 2017; 
Cameron et al. 2014; Ipsos MORI 2016). But across all sectors, we might not have 
full knowledge of the parties themselves or others to whom they may pass the data; 
and in the act of giving the matter more thought we might even skew our own per-
spectives. The extent to which this may occur depends on many factors, including 
the body of information that shapes our personal views and the most pervasive cur-
rent events in the media. It can be easy to demonise certain sectors wholescale, 
disregarding that they are not all one entity. This can be seen in public views on the 
pharmaceutical industry, towards whom distrust is often expressed. Although there 
have been some high-profile cases where pharma companies have behaved inap-
propriately with data (Cohen 2014; Goldacre 2013), poor research integrity is not 
necessarily limited to the private sector. It’s also worth remembering that pharma 
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companies create the majority of our medicines, and the cost of bringing a new drug 
to market can stretch to $billions (Herper 2017). This requires a major commitment 
and is one unlikely to be embarked on frivolously; although they profit, they also 
produce public good. When we engage with the public, or we are the individuals 
being engaged with, we need to take broader issues into account, beyond the imme-
diate. For example, by remembering that we donate our data to other major organ-
isations, such as via social media, with far less consideration and knowledge than 
participating in a research study, whether commercial or non-commercial. In this 
way, we can hope to gain a fuller picture before we make our decisions.
This leads nicely to the purposes for which our donated data are used, of which 
there will be far too many to consider here. But we can take a basic division between 
primarily for-profit and not-for-profit. Again, we are likely to be more permissive 
towards not-for-profit uses of our data. But even so, it is sometimes difficult to know 
exactly how data will be used. This is less likely to be an issue with data we provide 
as part of our receipt of healthcare. However, this is not failsafe, as there have been 
rare cases where large volumes of National Health Service data have been passed to 
third parties without due governance and leading to an outcry in the media (Hern 
2017). Properly-governed research from any sector should ideally include a research 
protocol with defined questions and data requirements. Clinical trials of medicinal 
products tend to have tightly-controlled specifications from the outset. But in other 
research designs, it is not always desirable or even possible to be completely defini-
tive at the start. Often research studies need to build in a degree of flexibility whilst 
operating within the bounds of regulatory approvals, including having a relevant 
lawful basis for processing the donated data. Where participant consent is relied 
upon, it must be properly informed and freely given. Thus we may have a conun-
drum in some research scenarios: unknown elements vs the need to inform. When 
this occurs, it is the duty of researchers to be upfront in the recruitment process so 
that participants have the best information available on which to base their deci-
sions. Across other for-profit domains where Pat may donate his data, the purposes 
of data use could be vaguer and more exploitative, as we’ve noted earlier.
As well as a measure of unknowns in the package, parties and purposes, we may 
also be faced with uncertainties in the places: that is, in the data environment. Data 
could be stored and managed in a myriad of ways, just some of which are outlined 
briefly since this is a vast subject beyond the scope of this chapter. They might 
reside in anything from a simple, locally-held database under the control of a single 
individual to a large-scale platform with privacy-by-design. The data could be 
stored on a single PC, on a local server, or on a cloud-based storage system operat-
ing across jurisdictions. They could be publically accessible, or subject to access 
restrictions, and they could be released externally or retained within a data safe 
haven. How and where the data are to be held is an essential data governance issue 
for the safe, secure use of data. It calls for assurance that security measures have 
been applied to mitigate risks, and that the data custodians can be considered trust-
worthy. This is needful, not just to satisfy regulatory authorities, but also in com-
municating with, and respecting, individuals donating their data. It is part of 
conveying transparent information to promote informed choice. Of course, it might 
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not be appropriate to describe the security model and control measures in technical 
detail, but it is important to do so in a way that enables individuals to understand the 
principles of how their data will be handled and protected. Again, it’s about clarity 
and the limits thereof. To complete our consideration of Ps and Qs, we ask what we 
can best do, and we propose that: as professionals we should be honest about uncer-
tainty to the best of our knowledge; and as individuals, we should recognise that 
there are sometimes limits in knowledge when working with data. Even so, all must 
be conducted with integrity and trustworthiness on all sides.
5.12  The Need for Innovation in Data Governance
Having established some of the many complexities and uncertainties to be taken 
into account in data donation, we propose that there is a strong need for innovation 
in data governance so that the best use of data can be made in safe, socially- 
acceptable ways. Pat’s data are subject to a range of factors influencing their trans-
formation into information, not limited to the specifications of legislation and 
regulations. There is a complex interplay between legislation and regulations, how 
they are interpreted and the body of knowledge that influences this process, such 
that the realisation of information from Pat’s data, in all its manifestations, is depen-
dent on a variety of factors. These instruments give rise to broader ethical, legal and 
societal issues (ELSI), implementation frameworks and due diligence processes. In 
line with the famous adage that ‘in theory there is no difference between theory and 
practice: in practice there is’, implementation is dependent on interpretation. 
Different individuals and organisations will have their own perceptions, risk appe-
tites and motivations in coming to an opinion on a data governance issue. As well as 
that, these perceptions are coloured by the body of opinion coming from stakehold-
ers and the wider media. In these respects, this is a prime example of our life through 
a lens illustration. As we’ve noted, the ‘big data’ landscape is one that is expanding 
rapidly, with increases not just in data volumes but also in data types being donated. 
These emerging types, such as genomic, imaging, free-text, social media and smart 
object data can stretch current data governance regimes. They call for innovative 
solutions to avoid undue bureaucracy and support the safe, socially-acceptable use 
of donated data. It is a positive step that the GDPR has introduced measures to 
strengthen individual rights over their personal data, and to limit exploitative activi-
ties such as automated profiling (Intersoft consulting 2017). But even so, data ana-
lytics often run in advance of ELSI-based solutions, particularly in areas where data 
are seen as a lucrative commodity. Thus, there is a need for innovation to enable 
safe, effective data use without undue bureaucracy.
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5.13  Who Are You, Who, Who, Who, Who?7
By now, we might really want to know what our role as individuals and profession-
als can be or should be in relation to the complex issue of data donation. This, of 
course, will depend on a multiplicity of factors, and is really only a question we can 
answer for ourselves in relation to each data donation instance. But it is worth con-
sidering some of the factors that may dictate our role. Firstly, our views are likely to 
be strongly influenced depending whether we ourselves are the data donor, whether 
they relate to our close kin, and the perceived sensitivity of the likely data content. 
Whether we realise it fully or not, our thinking is shaped by our worldview and the 
vast, shifting body of knowledge that floats around shaping our social realities that 
we mentioned earlier. We also have the urgency of the issue versus the distance from 
the issue, and whatever defines that concept in a given instance. Furthermore, as we 
have shown, we are often likely to be dealing with incomplete information on which 
to base our choices. Altogether, it’s not surprising that Pat may find himself in a 
quandary when he has to come out of his comfort zone and make important deci-
sions about his data. Though painful, this can actually be a good thing, on the basis 
that at least he can question his position and the information being presented to him 
in making his choices. For Pat, and any of us, there are likely to be occasions where 
we need to take on different roles to fulfil our familial and social responsibilities. 
We might be leading, shaping a situation, or basically a follower guided by others. 
The key, in all cases is to seek and provide the best available information to inform 
decisions. There are various versions of the phrase: ‘without data, all decisions are 
guesswork’, and ultimately, our aim is the safe, socially-acceptable, increasing use 
of data for public good. The alternative is unthinkable.
5.14  Finding the Black Cat in the Dark Room
There is no doubt that data saves lives, and this phrase itself is the rallying cry of a 
major public engagement campaign to highlight the value of health data, and to 
encourage people to pledge their support for their safe re-use in research for the 
benefit of individuals and society (Farr Institute of Health Informatics Research 
2018). Earlier, we looked briefly at the influence of poor information governance 
practice on the non-use of health data. Let’s look at the implications of data non-use 
in a little more detail. The aforementioned international case study covered the non- 
use of health data across clinical records and research domains, as well as in relation 
to governance regimes (Jones et al. 2017). From this study, it became evident that 
there are multiple reasons for data non-use, compounding each other and resulting 
in serious harm to individuals and society. As a result, health data non-use has been 
strongly implicated in hundreds of thousands of deaths and £billions in financial 
7 Who are you? (Pete Townsend, The Who).
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burdens to societies (Jones et al. 2017). It is a challenging issue to study, as harm 
due to data non-use is difficult to attribute unequivocally, but there is no doubt that 
this black cat certainly is there. The study concluded that, although there are many 
initiatives seeking to address this problem, much more needs to be done. The most 
effective moves are likely to be those that that: (i) uncover the sources, types and 
reasons for data non-use in a given domain; and (ii) recognise the multiple aspects 
to this complex issue across other domains in seeking solutions to move steadily 
towards socially responsible reuse of data becoming the norm. Pat’s life is at stake 
here, and it has even been argued that harm due to data non-use is a greater risk than 
data misuse (St. Clair 2008). Unlike Schrodinger’s pet, it is most certainly alive and 
manifests itself globally as a large, agile, polymorphic, lethal, black cat that must be 
captured and tamed.
5.15  Conclusion
Having considered some of the incongruities, dilemmas, risks and benefits in data 
donation, we argue that on balance it is not ethical for the vast, increasing swathes 
of data donated in good faith by individuals not to be used for public good. 
Determining what constitutes public good is another issue in itself and one that has 
not been explored here. It appears that, in common with other aspects of life, indi-
viduals might simultaneously hold conflicting beliefs with regards to data donation. 
The challenge lies in finding a bioethical balance between individual autonomy, 
personal exploitation and social responsibility, when our knowledge is incomplete 
and powerful actors have their own agendas. But to use one more analogy, let’s not 
throw out the baby with the bathwater, but endeavour to pursue the best information 
we can obtain.
The demand for personal data is massive and multi-faceted, and it is in our inter-
ests to be guarded in our influences and to invest our trust with caution. Our ultimate 
question was whether we, as individuals and society, can make truly informed 
choices about data donation with the panoply of issues that may influence our deci-
sions. This might not be a question that can be answered with a straightforward yes 
or no, for all the reasons we have discussed in this chapter, and more besides. It 
might well be impossible for any individual to comprehend the breadth of data use 
and its implications, but if we provide the best available information and engage 
properly with the information presented to us, we stand a more reasonable chance. 
To do that, there is an obvious need for carefully placed trust, demonstrable trust-
worthiness, and for Pat to hone his juggling skills.
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